Correlation between oxidative stress and clopidogrel drug in Iraqi patients with coronary artery disease

https://doi.org/10.53730/ijhs.v6nS9.12434

Authors

  • Likaa K. Khudair Department of Chemistry, College of Sciences, University of Baghdad, Baghdad, Iraq
  • Ali W. Al-Ani Department of Chemistry, College of Sciences, University of Baghdad, Baghdad, Iraq

Keywords:

catalase, coronary artery disease, oxidative stress, total antioxidant capacity, total oxidant capacity

Abstract

Background: Coronary Artery Disease (CAD) is one of the largest causes of mortality worldwide. Clopidogrel, antiplatelet drug, has been widely used for management of CAD. The current study aimed to investigate the effect of clopidogrel on the oxidative stress in CAD patients. Methods: One hundred CAD patients, who were followed-up for 5 days after receiving clopidogrel, and 50 healthy volunteers were included in this study. Parameters include catalase (CAT), total antioxidant capacity (TAC), total oxidant capacity (TOC), total protein, albumin, and globulins were determined before and after treatment with clopidogrel. Results: CAT, TAC, and Tp were significantly decreased (P<0.0001) in CAD patients compared to healthy control and the levels of these parameters were returned to increase after receiving clopidogrel. However, TOC level was markedly increased (P<0.0001) in CAD patients and returned to decrease after treating with clopidogrel. Receiver operating characteristic curve showed that CAT gave a higher sensitivity (68-73%) and specificity (72%) as an indicator for monitoring of CAD progression. Conclusion: CAT activity and TAC were significantly increased as a response of receiving clopidogrel which is helpful to reduce the risk of CAD through scavenging of oxidants formation. These results also present CAT as a predictor variable of clopidogrel action.

Downloads

Download data is not yet available.

References

A. A. Korish, "Clopidogrel prophylaxis abates myocardial ischemic injury and inhibits the hyperlipidemia-inflammation loop in hypercholestrolemic mice," Archives of Medical Research, vol. 51, pp. 515-523, 2020.

A. Nandi, L.-J. Yan, C. K. Jana, and N. Das, "Role of catalase in oxidative stress-and age-associated degenerative diseases," Oxidative medicine and cellular longevity, vol. 2019, 2019.

A. W. Al-Ani and S. S. Fadel, "Arlyesterase activity of Paraoxonase-1 enzyme in Iraqi patients with β-thalassemia minor."

A. W. Numan, "Study on total peroxidase enzymes activities and some trace elements in patients with breast tumors," Iraqi Journal of Biotechnology, vol. 9, pp. 828-837, 2010.

B. S. Kadhum and S. A. W. Al-Shammaree, "Association of Iron Status in Follicular Fluid with Pregnancy Outcomes in Infertile Women Undergoing IVF/ICSI," Iraqi Journal of Science, pp. 1779-1786, 2021.

E. Taylor, Y. Kim, K. Zhang, L. Chau, B. C. Nguyen, S. Rayalam, et al., "Antiaging Mechanism of Natural Compounds: Effects on Autophagy and Oxidative Stress," Molecules, vol. 27, p. 4396, 2022.

El-den Abd Elsalam, M. S. ., Abd Elbast, M. A., Mohamed, O. E., & El Tayeb, A. (2022). Comparison between Non-obstructive versus obstructive coronary artery disease patients with acute coronary syndrome. International Journal of Health Sciences, 6(S1), 9130–9143. https://doi.org/10.53730/ijhs.v6nS1.7065

F. Bulut, A. T. Tetiker, A. Çelikkol, A. Yılmaz, and B. Ballica, "Low antioxidant enzyme levels and oxidative stress in laryngopharyngeal reflux (LPR) patients," Journal of Voice, 2021.

G. Patti, G. Micieli, C. Cimminiello, and L. Bolognese, "The role of clopidogrel in 2020: a reappraisal," Cardiovascular therapeutics, vol. 2020, 2020.

H. R. Hasan and A. W. Numan, "BIOCHEMICAL STUDY ON SUPEROXIDE DISMUTASE ENZYME IN PATIENTS WITH DIFFERENT BRAIN TUMORS."

H. R. Hasan and A. W. Numan, "Extracellular superoxide dismutase changes in patients with different brain tumors," Iraqi Journal of Science, vol. 50, pp. 1-7, 2009.

J. Mates, "Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology," Toxicology, vol. 153, pp. 83-104, 2000.

J. Pang, Q. Wu, Z. Zhang, T.-z. Zheng, Q. Xiang, P. Zhang, et al., "Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention: A systematic review and meta-analysis," IJC Heart & Vasculature, vol. 23, p. 100317, 2019.

J.-P. Maffrand, "The story of clopidogrel and its predecessor, ticlopidine: Could these major antiplatelet and antithrombotic drugs be discovered and developed today?," Comptes Rendus Chimie, vol. 15, pp. 737-743, 2012.

K. F. Zahra, R. Lefter, A. Ali, E.-C. Abdellah, C. Trus, A. Ciobica, et al., "The involvement of the oxidative stress status in cancer pathology: a double view on the role of the antioxidants," Oxidative Medicine and Cellular Longevity, vol. 2021, 2021.

K. Wahabi, A. Perwez, and M. A. Rizvi, "Antioxidant in Cancer: Preventer, Promoter or an Achilles Heel," in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, ed: Springer, 2022, pp. 1-16.

L. Góth, Á. Lenkey, and W. N. Bigler, "Blood catalase deficiency and diabetes in Hungary," Diabetes care, vol. 24, pp. 1839-1840, 2001.

L. Wang, J. Wang, J. Xu, W. Qin, Y. Wang, S. Luo, et al., "The Role and Molecular Mechanism of P2Y12 Receptors in the Pathogenesis of Atherosclerotic Cardiovascular Diseases," Applied Sciences, vol. 11, p. 9078, 2021.

M. A. Khan, M. J. Hashim, H. Mustafa, M. Y. Baniyas, S. K. B. M. Al Suwaidi, R. AlKatheeri, et al., "Global epidemiology of ischemic heart disease: results from the global burden of disease study," Cureus, vol. 12, 2020.

M. Tiedge, S. Lortz, J. Drinkgern, and S. Lenzen, "Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells," Diabetes, vol. 46, pp. 1733-1742, 1997.

M. Tiedge, S. Lortz, R. Munday, and S. Lenzen, "Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species," Diabetes, vol. 47, pp. 1578-1585, 1998.

Miharja, M. ., Setiawati, S. ., & Lubis, A. L. P. . (2020). How dangerous the Indonesian recession due to COVID-19 pandemic: review policy and strategy to recovery. International Journal of Social Sciences and Humanities, 4(3), 121–129. https://doi.org/10.29332/ijssh.v4n3.470

N. Aladağ, R. Asoğlu, M. Ozdemir, E. Asoğlu, A. R. Derin, C. Demir, et al., "Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI)," Journal of Medical Biochemistry, vol. 40, p. 286, 2021.

N. Gupta, K. Verma, S. Nalla, A. Kulshreshtha, R. Lall, and S. Prasad, "Free radicals as a double-edged sword: The cancer preventive and therapeutic roles of curcumin," Molecules, vol. 25, p. 5390, 2020.

N. K. Hussain, S. S. Rzoqi, A. W. Numan, and D. T. Ali, "A comparative study of fructose, zinc and copper levels in seminal plasma in fertile and infertile men," Iraqi J Med Sci, vol. 48, 2000.

P. Garcia-Caparros, L. De Filippis, A. Gul, M. Hasanuzzaman, M. Ozturk, V. Altay, et al., "Oxidative stress and antioxidant metabolism under adverse environmental conditions: a review," The Botanical Review, vol. 87, pp. 421-466, 2021.

P. Krishnamurthy and A. Wadhwani, "Antioxidant enzymes and human health," Antioxidant enzyme, vol. 1, pp. 3-18, 2012.

P. Pignatelli, D. Menichelli, D. Pastori, and F. Violi, "Oxidative stress and cardiovascular disease: new insights," Kardiologia Polska (Polish Heart Journal), vol. 76, pp. 713-722, 2018.

R. Caruso, S. Rocchiccioli, A. M. Gori, A. Cecchettini, B. Giusti, G. Parodi, et al., "Inflammatory and antioxidant pattern unbalance in “clopidogrel-resistant” patients during acute coronary syndrome," Mediators of Inflammation, vol. 2015, 2015.

R. H. Jasim, A. W. Numan, and S. M. Hasan, "Evaluation of oxidative stress and liver function parameters in the sera samples of Kufa cement factory workers," Journal of Kufa for Chemical Science, vol. 6, pp. 40-50, 2012.

S. Bartimoccia, C. Nocella, D. Pastori, P. Pignatelli, and R. Carnevale, "Platelet oxidative stress and antioxidant nutrients," Journal of Vascular Medicine & Surgery, 2014.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

T. Heitzer, V. Rudolph, E. Schwedhelm, M. Karstens, K. Sydow, M. Ortak, et al., "Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects," Arteriosclerosis, thrombosis, and vascular biology, vol. 26, pp. 1648-1652, 2006.

T. Senoner and W. Dichtl, "Oxidative stress in cardiovascular diseases: still a therapeutic target?," Nutrients, vol. 11, p. 2090, 2019.

X. An, G. Jiang, C. Cheng, Z. Lv, Y. Liu, and F. Wang, "Inhibition of platelets by clopidogrel suppressed Ang II‐induced vascular inflammation, oxidative stress, and remodeling," Journal of the American Heart Association, vol. 7, p. e009600, 2018.

Published

03-09-2022

How to Cite

Khudair, L. K., & Al-Ani, A. W. (2022). Correlation between oxidative stress and clopidogrel drug in Iraqi patients with coronary artery disease. International Journal of Health Sciences, 6(S9), 1164–1174. https://doi.org/10.53730/ijhs.v6nS9.12434

Issue

Section

Peer Review Articles